|
 Dementia
 Merz - our research for your health. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease.
Dementia: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Dementia is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Dementia now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Dementia very serious, so that we can offer you the best drug for each treatment and therapy you need. Dementia and Merz means research for your health. High-quality products and information about Dementia can be found on our website. Visit us online and learn everything about Dementia from one of Germany's leading health care companies. Our contribution to Dementia: read here what we can do for you. Further links: Axura: Information for professionals.>>
Dementia and Merz means research for your health.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A significant improvement in cognitive performance is seen during treatment with the NMDA antagonist, especially when only small vessels are affected. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Glutamate stimulates a number of postsynaptic receptors, including the N-methyl-D-aspartate (NMDA) receptor, which has been particularly implicated in memory processes, dementia, and the pathogenesis of Alzheimer's disease. The intracellular calcium pool is reduced, and the noise lower. Memantine has been developed as a monotherapeutic. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . The safety of the combination therapy was investigated in a postmarketing surveillance study. Glutamate is the principal neurotransmitter in the brain. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Gedächtnis , Demenz . Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms). Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Memantine produces symptomatic improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer s disease. Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Dementia
|
